Zobrazeno 1 - 10
of 98
pro vyhledávání: '"Athos Bousvaros"'
Autor:
Kimberly N Weaver, Xian Zhang, Xiangfeng Dai, Runa Watkins, Jeremy Adler, Marla C Dubinsky, Arthur Kastl, Athos Bousvaros, Jennifer A Strople, Raymond K Cross, Peter D R Higgins, Ryan C Ungaro, Meenakshi Bewtra, Emanuelle Bellaguarda, Francis A Farraye, Margie E Boccieri, Ann Firestine, Michael D Kappelman, Millie D Long
Publikováno v:
Inflammatory Bowel Diseases. 28:1497-1505
Background Severe acute respiratory syndrome coronavirus 2 vaccination is recommended for all individuals with inflammatory bowel disease (IBD), including those on immunosuppressive therapies; however, little is known about vaccine safety and efficac
Autor:
Michael D. Kappelman, Kimberly N. Weaver, Xian Zhang, Xiangfeng Dai, Runa Watkins, Jeremy Adler, Marla C. Dubinsky, Arthur Kastl, Athos Bousvaros, Jenifer A. Strople, Raymond K. Cross, Peter D.R. Higgins, Ryan C. Ungaro, Meenakshi Bewtra, Emanuelle A. Bellaguarda, Francis A. Farraye, Margie E. Boccieri, A. Firestine, Kelly Y. Chun, Manory Fernando, Monique Bastidas, Michael Zikry, Millie D. Long
Publikováno v:
The American journal of gastroenterology. 117(3)
Although an additional coronavirus disease 2019 vaccine dose for immunocompromised persons has been recommended in some countries, further data to guide vaccination strategies for patients with inflammatory bowel disease (IBD) are urgently needed. We
Autor:
Jorge Amil Dias, Baruch Yerushalmi, Dan Turner, Gigi Veereman Wauters, Athos Bousvaros, G Abitbol, Rotem Sigall Boneh, Mona Boaz, Eytan Wine, J. Kierkus, Malgorzata Sladek, Johanna C. Escher, Arie Levine, Michal Kori, Ron Shaoul
Publikováno v:
Gut, 68(2), 239-247. BMJ Publishing Group
ObjectiveCrohn’s disease (CD) pathogenesis associated with dysbiosis and presence of pathobionts in the lumen, intracellular compartments and epithelial biofilms. Azithromycin is active in all three compartments. Our goal was to evaluate if azithro
Publikováno v:
Journal of Pediatric Surgery. 53:1330-1333
Background Vedolizumab is a biologic, which inhibits leukocyte adhesion in the gut and is used to treat ulcerative colitis (UC) and Crohn's disease (CD). Little is known of the surgical outcomes in patients treated with vedolizumab. We reviewed the p
Autor:
Raif S. Geha, Juan Manuel Leyva Castillo, Janet Chou, Fatma Dedeoglu, Jeff Goldsmith, Wayne Bainter, Yousef R. Badran, Athos Bousvaros, Toshiro K. Ohsumi
Publikováno v:
The Journal of Experimental Medicine
Badran et al. demonstrate an essential contribution of biallelic RELA expression in protecting stromal and epithelial cells from TNF-mediated cell death in patients with chronic mucocutaneous ulceration.
The treatment of chronic mucocutaneous ul
The treatment of chronic mucocutaneous ul
Autor:
Wendy K.M. Liew, Peter B. Kang, Basil T. Darras, Athos Bousvaros, Nicole Visyak, Christina A. Pacak
Publikováno v:
The Journal of Pediatrics. 178:227-232
Objective To characterize the longitudinal clinical and electrophysiological patterns of thalidomide neuropathy in children and adolescents. Study design Retrospective analysis of clinical records at a tertiary care children's hospital, including ser
Publikováno v:
Journal of pediatric gastroenterology and nutrition. 68(6)
Background Microscopic ileitis and its association with pancolitis in adults with ulcerative colitis (UC) have been described. The incidence of ileitis and associations with colonic disease in pediatric UC have, however, not been thoroughly investiga
Publikováno v:
World Journal of Gastroenterology
Background There is a small and poorly studied population of patients with mild and limited Crohn's disease (CD), who either spontaneously enter remission and can discontinue therapy, or be maintained on milder anti-inflammatory treatment. Aim To ide
Autor:
Daniel D. Sprockett, Baruch Yerushalmi, Natalie Fischer, Athos Bousvaros, Rotem Sigall Boneh, J. Kierkus, Scott B. Snapper, Jorge Amil Dias, Eytan Wine, David A. Relman, Susan Holmes, Ron Shaoul, Dan Turner, Johanna C. Escher, Malgorzata Sladek, Michal Kori, Arie Levine
Publikováno v:
Inflammatory Bowel Diseases, 25(12), 1927-1938. Oxford University Press
Inflamm Bowel Dis
Inflamm Bowel Dis
Background The beneficial effects of antibiotics in Crohn’s disease (CD) depend in part on the gut microbiota but are inadequately understood. We investigated the impact of metronidazole (MET) and metronidazole plus azithromycin (MET+AZ) on the mic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efe296ff8c5ec076b2f5b7342769ef13
https://pure.eur.nl/en/publications/f16c5173-0694-4c6d-9f60-ccc4c6d13d6a
https://pure.eur.nl/en/publications/f16c5173-0694-4c6d-9f60-ccc4c6d13d6a
Autor:
Louis M. Kunkel, Helen C. Hood, Richard J. Grand, Vladimir I. Valtchinov, Jocelyn A. Silvester, Nathan Palmer, Inbar Fried, Athos Bousvaros, Saum Ghodoussipour, Sek Won Kong, Fedik Rahimov, Isaac S. Kohane, Andrew L. Beam, Jessica J. Lee
Publikováno v:
PLoS ONE, Vol 14, Iss 10, p e0222952 (2019)
PLoS ONE
PLoS ONE
Background Presenting features of inflammatory bowel disease (IBD) are non-specific. We hypothesized that mRNA profiles could (1) identify genes and pathways involved in disease pathogenesis; (2) identify a molecular signature that differentiates IBD